How is ST‑segment‑elevation myocardial infarction (STEMI) detected?

How to Detect STEMI

A 12-lead ECG should be performed and interpreted within 10 minutes of patient arrival for anyone with chest discomfort or symptoms suggestive of acute myocardial infarction, as this is the cornerstone diagnostic test for STEMI. 1

Primary Diagnostic Approach

Immediate ECG Acquisition and Interpretation

• Obtain a 12-lead ECG within 10 minutes of emergency department arrival (or first medical contact in prehospital settings) for all patients presenting with chest discomfort, anginal equivalents, or symptoms suggestive of STEMI 1

• The ECG is the central diagnostic tool because ST-segment elevation identifies patients who benefit from immediate reperfusion therapy 1

ECG Diagnostic Criteria for STEMI

The diagnosis requires new ST-segment elevation at the J-point in at least 2 contiguous leads with the following thresholds 2:

For leads V2-V3:

• ≥2.0 mm (0.2 mV) in men ≥40 years
• ≥2.5 mm (0.25 mV) in men <40 years
• ≥1.5 mm (0.15 mV) in women

For all other leads:

• ≥1.0 mm (0.1 mV) in contiguous chest or limb leads 2

Serial ECG Monitoring

• If the initial ECG is non-diagnostic but clinical suspicion remains high, perform serial ECGs at 5-10 minute intervals or use continuous 12-lead ST-segment monitoring to detect evolving ST elevation 1

• This is critical because STEMI may develop over time in patients with ongoing symptoms 1

Supplementary ECG Leads for Specific Scenarios

Right Ventricular Infarction

• In patients with inferior STEMI (ST elevation in leads II, III, aVF), obtain right-sided ECG leads (V3R and V4R) to screen for ST elevation suggestive of right ventricular infarction 1

Posterior Myocardial Infarction

• Use posterior chest leads V7-V9 (≥0.5 mm or 0.05 mV elevation) in patients with suspected posterior (inferobasal) MI, which may present with isolated ST-depression in leads V1-V3 3, 2

Atypical ECG Presentations Requiring Emergency Angiography

Certain presentations warrant the same urgent treatment as STEMI despite not meeting classic criteria 3:

• Left bundle branch block (LBBB) with ongoing ischemic symptoms (though LBBB alone should not be considered diagnostic of acute MI) 2, 3
• Ventricular paced rhythm with persistent ischemic symptoms 3
• Isolated posterior MI with ST-depression ≥0.05 mV in V1-V3 as the dominant finding 3
• ST elevation in lead aVR with widespread ST-depression suggesting left main or multivessel disease 3

Clinical History and Physical Examination

Targeted History Elements

Focus on 1:

• Chest discomfort characteristics: central/substernal compression or crushing pain, radiation to neck, jaw, shoulders, back, or arms
• Associated symptoms: nausea/vomiting, dyspnea, diaphoresis, weakness, dizziness
• Prior cardiac history: previous angina, MI, CABG, or PCI
• Risk factors: hypertension, diabetes mellitus
• Sex and age-related presentation differences (elderly and women may present atypically with fatigue or dyspnea rather than chest pain) 1
• Contraindications to reperfusion: possibility of aortic dissection, bleeding risk, prior stroke 1

Physical Examination Findings

Look for 1, 4:

• Autonomic activation: pallor, sweating
• Hemodynamic status: hypotension, narrow pulse pressure, or hypertension
• Cardiac findings: third heart sound (S3), irregular pulse, bradycardia or tachycardia
• Pulmonary findings: basal rales suggesting heart failure
• Brief neurological examination before fibrinolytic therapy to detect prior stroke or cognitive deficits 1

Role of Cardiac Biomarkers

Critical Timing Principle

Do not wait for cardiac biomarker results to initiate reperfusion therapy 1

• For patients with ST elevation on ECG and symptoms of STEMI, reperfusion therapy should be initiated immediately and is not contingent on biomarker assays 1

• The diagnosis of STEMI is secure based on ECG findings alone 1

Appropriate Use of Biomarkers

• Cardiac-specific troponins are the optimal biomarkers, particularly in patients with coexistent skeletal muscle injury 1

• Biomarkers provide prognostic information and can offer supportive evidence of successful reperfusion after fibrinolytic therapy, but should not delay treatment 1

• Serial biomarker measurements should not be relied upon to diagnose reinfarction within the first 18 hours after STEMI onset 1

Adjunctive Imaging When Diagnosis is Unclear

Echocardiography

• Portable bedside echocardiography is reasonable to clarify the diagnosis when STEMI is confounded by LBBB, pacing, or suspected posterior STEMI with anterior ST depressions 1

• Regional wall motion abnormalities occur within seconds of coronary occlusion, well before necrosis develops 3, 4

• Two-dimensional echocardiography is particularly valuable for diagnosing alternative causes: aortic dissection, pericardial effusion, or massive pulmonary embolism 3, 4, 1

• The absence of wall motion abnormalities effectively excludes major myocardial infarction 3, 4

Other Imaging

• Chest X-ray should be obtained but must not delay reperfusion therapy unless aortic dissection is suspected 1

• CT scan or MRI may be used to differentiate STEMI from aortic dissection when the distinction is initially unclear 1

Common Pitfalls to Avoid

Diagnostic Accuracy Challenges

• Physician interpretation of STEMI ECGs shows significant variability, with interreader agreement (kappa) of only 0.33 and sensitivity of 65% in one study 5

• ST elevation alone (≥1 mm) has a positive predictive value of only 49% for MI; requiring reciprocal changes improves positive predictive value to 93-95% 6

• In-hospital STEMI is frequently missed because patients less often present with typical angina, and ECGs may be obtained only after changes in clinical status or elevated biomarkers are noted 7

Time-Critical Actions

The overarching goal is to achieve door-to-needle time within 30 minutes for fibrinolysis or door-to-balloon time within 90 minutes for primary PCI 1

• Any delay in ECG acquisition, interpretation, or activation of reperfusion protocols directly worsens outcomes 7